Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States
Authors
Keywords
-
Journal
Diabetes Therapy
Volume 12, Issue 8, Pages 2223-2239
Publisher
Springer Science and Business Media LLC
Online
2021-07-18
DOI
10.1007/s13300-021-01110-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem
- (2021) Massimo Cugno et al. ADVANCES IN THERAPY
- Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
- (2021) Ranu Baral et al. JAMA Network Open
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
- (2020) Kui Liu et al. CHINESE MEDICAL JOURNAL
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
- (2020) Daniel J Drucker ENDOCRINE REVIEWS
- Coronavirus disease 2019 (COVID-19): current status and future perspectives
- (2020) Heng Li et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
- (2020) Jing Yang et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Covid-19: risk factors for severe disease and death
- (2020) Rachel E Jordan et al. BMJ-British Medical Journal
- Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
- (2020) Christopher M Petrilli et al. BMJ-British Medical Journal
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
- (2020) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
- (2020) Awadhesh Kumar Singh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin in COVID-19: A possible role beyond diabetes
- (2020) Swati Sharma et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Practical recommendations for the management of diabetes in patients with COVID-19
- (2020) Stefan R Bornstein et al. Lancet Diabetes & Endocrinology
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
- (2020) Naomi Holman et al. Lancet Diabetes & Endocrinology
- The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis
- (2020) Jiuyang Xu et al. CLINICAL INFECTIOUS DISEASES
- Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19
- (2020) Jacqueline Seiglie et al. DIABETES CARE
- Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
- (2020) Bo Yu et al. Cell Metabolism
- Metformin and Autoimmunity: A “New Deal” of an Old Drug
- (2018) Francesco Ursini et al. Frontiers in Immunology
- Diabetes Complications Severity Index (DCSI)—Update and ICD-10 translation
- (2017) William P. Glasheen et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started